Physician profile

Rebekah Boring

Foot & Ankle Surgery · Chambersburg, PA

NPI 1699207365

$2,522.27

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$644.24
Food and Beverage$76.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Fortis Surgical, LLC $1,612.05 2019
Treace Medical Concepts, INC. $647.31 2023
Stryker Corporation $136.12 2020
Novus Surgical Consultants $59.25 2024
Mallinckrodt Enterprises LLC $26.13 2019
Zimmer Biomet Holdings, INC. $24.85 2021-2024 Gel-One Cross-Linked Hyaluronate, Gps III Platelet Concentration System, Biocue
Depuy Synthes Sales INC. $16.56 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rebekah Boring

$2,522.27

in general payments reported 2019-2025

Years
2019-2024
Top company
Fortis Surgical, LLC

https://glasscript.com/doctor/7222886/rebekah-boring

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.